[ Price : $8.95]
Purdue Pharma asks FDA not to approve any ANDAs or new drug applications referencing its Butrans transdermal system unless the fol...[ Price : $8.95]
Gilead asks FDA to reconsider its decision not to grant NCE exclusivity to its Stribild in light of a recent DC federal court deci...[ Price : $8.95]
FDAers Jonathan Goldsmith and Sandra Kweder describe the work of two new partnership clusters with EMA staff.[ Price : $8.95]
FDAs Cincinnati District Office warns Vetix about multiple violations in its manufacture and distribution of animal drug products....[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Eagle Pharmacy, SaveWay Compounding Pharmacy, U.S. Specialty Formulations, Unive...[ Price : $8.95]
Medtronic Neurovascular Products recalls certain lots of its Pipeline embolization device, Alligator retrieval device and X-Celera...[ Price : $8.95]
FDAs Philadelphia District Office warns U.S. Specialty Formulations about violations in its work as a compounded drug outsourcing ...[ Price : $8.95]
CBER extends its strategic plan for two years with six goals and associated objectives and strategies.